Asan Medical Center Accelerates New Drug Development with AI Medical Imaging Analysis Technology
Published
Recently, the Clinical Trial Center at Asan Medical Center discussed methods for utilizing artificial intelligence (AI) technology in medical imaging analysis. The discussion focused on how to efficiently apply data analyzed by AI to the processes of new drug development and clinical trials.
In clinical settings, AI technology helps analyze patient images more quickly and accurately. The hospital aims to standardize these AI analysis metrics to enhance the reliability of new drug development research and shorten development timelines.
Experts expect that the introduction of this technology will significantly improve the accuracy of clinical trials. In particular, by having AI systematically organize complex medical data, it is expected that an environment will be created where researchers can focus on more critical decision-making.
Asan Medical Center plans to further define the standardization tasks for this technology to strengthen the competitiveness of the domestic pharmaceutical industry. If this research is successfully established, it is expected that more patients will be able to access new treatments more rapidly.
Sources: 메디포뉴스
More South Korea news
- Digital TVET master's program launches in South Korea
- Gyeongbuk health group donates 100 boxes of grapes to children
- US Big Tech Pursues Multi-Trillion Won Investments in South Korean Data Centers Amid Uncertainty
- KB Insurance to Hold Open Recruitment for New Employees in Second Half of 2026
- Kolmar Korea Wins CES Beauty Tech Best Innovation Award for Second Straight Year, Setting World First
- China Closes In on Korea's Core LNG Carrier Market, Expanding from Mega-Vessels to Equipment
- China's Rapid Technological Development: South Korea Must Change Its Regulations and Labor System
- Ambassador Michelle Steel: American Companies Operating in Korea Should Compete in a Fair Environment